Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: Glencore Non-Executive Cuts Stake

Fri, 22nd May 2015 13:01

Director Dealings Summary - Week Ended May 22        
Company Name Position Number of Shares Resulting Holding *Note GBP Value
             
BUYS            
             
Topps Tiles Matthew Williams CEO 1 million 1.7 million   1,270,000
Countrywide Alison Platt CEO 41,700 41,700 Appointed CEO in September 2014. 248,000
Rank Group Henry Birch CEO 100,000 100,000 Same day as  Rank said it expects  full year results to meet management expectations.  205,000
Homeserve John Gibson Chairman 40,000 115,000 Day after reporting higher profit and said it would pay a special dividend of GBP97 million. 172,000
Sage Group Jonathan Howell Non-Executive Director 18,167 Undisclosed   103,000
AG Barr Stuart Lorimer CFO 14,000 1.1 million   87,000
Homeserve Ben Mingay Non-Executive Director 20,000 40,000 Day after reporting higher profit and said it would pay a special dividend of GBP97 million. 86,000
Inspired Capital Jeremy Coombes Interim CEO 535,000 2.9 million   75,000
Rank Group Clive Jennings CFO 25,000 25,000 Same day as  Rank said it expects  full year results to meet management expectations..  51,000
STM Group Michael Riddell Chairman 137,000 Undisclosed Week after STM said it made good start to 2015 and said trading so far this year is in line with its expectations. 49,000
Homeserve Stella David Non-Executive Director 10,450 28,138 2 days after reporting higher profit and said it would pay a special dividend of GBP97 million. 45,000
Mitchells & Butlers Eddie Irwin Non-Executive Director 10,000 30,000   45,000
Amara Mining John McGloin Chairman 271,249 1.6 million   41,000
McBride Chris Smith CFO 25,657 25,657 Appointed in January. 24,000
Oxford Biomedica Tim Watts CFO 194,174 5.8 million   19,000
Symphony Environmental Michael Stephen Deputy Chairman 151,000 933,998   15,000
Symphony Environmental Michael Laurier CEO 150,000 23 million   14,000
Verona Pharma David Ebsworth Chairman 300,000 3.6 million Week after Verona Pharma  posted a widened pretax loss for 2014. 11,000
Lekoil Greg Eckersley Non-Executive Director 50,000 2.8 million Week after Lekoil said its pretax loss narrowed as administrative and finance costs fell. 10,000
Oxford Biomedica Andrew Heath Non-Executive Director 100,000 1.1 million   10,000
Mortgage Advice Bureau Lucy Tilley CFO 4,500 4,500 Appointed in March. Was previously a director in Canaccord Genuity's corporate broking team, which worked on company's AIM listing. 9,900
Airea Roger Salt CFO 58,738 228,738   9,000
Symphony Environmental Ian Bristow CFO 100,000 1.2 million   9,000
K3 Business Technology Brian Davies CFO 2,253 9,537 Bought shares from CEO David Bolton 5,600
Verona Pharma Biresh Roy CFO 150,000 900,000 Week after Verona Pharma  posted a widened pretax loss for 2014. 5,000
Symphony Environmental Nirj Deva Chairman 50,000 363,925   4800
Verona Pharma Jan-Anders Karlsson CEO 135,000 2.9 million Week after Verona Pharma  posted a widened pretax loss for 2014. 4,700
Symphony Environmental Nicholas Clavel Non-Executive Director 50,000 550,000   4,500
             
SELLS            
             
Glencore William Macaulay Non-Executive Director 28 million 42 million Sold by FR Galaxy Holdings, an investment vehicle connected to Macaulay. 84,000,000
Moneysupermarket Simon Nixon Founder & non-executive deputy chairman 20 million 69.8 million The amount of shares sold is at the top end of the range. Credit Suisse, the sole bookrunner on the placing, said it would sell a stake of between 2.8% and 3.7% on behalf of Nixon, who retains a 12.8% holding. 56,000,000
Merlin Entertainments Nick Mackenzie Manager 440,000 1.5 million Same day as Merlin reported growth in revenue boosted by new site openings, features and good weather, as it continues strategic expansion plans. 2,000,000
Countrywide Grenville Turner Chairman 300,000 171,524   1,800,000
Hays Paul Venables CFO 750,000 953,014   1,200,000
Sthree Justin Hughes Corporate Executive Officer 267,500 390,867 Has sold parcels of shares in quick succession since May 12. 1,000,000
Euromoney Peter Ensor Chairman 20,421 175,918 Same day as interim ex-dividend date. 245,000
Bloomsbury Publishing Nigel Newton CEO 132,651 1.1 million Day after Bloomsbury posted a small rise in pretax profit and said trading in its current year has been good across all of its divisions. 232,000
ITV David Osborn HR Director 35,900 Nil   97,000
Rolls-Royce Jason Smith Divisional CEO 2,850 19,582   29,000
K3 Business Technology David Bolton CEO 2,253 994,961 Sold shares to CFO Brian Davies.  
             
*Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event.
When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director
             
Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam      
             
Copyright 2015 Alliance News Limited. All Rights Reserved.        

More News
8 May 2015 15:19

Earnings, Trading Statements Calendar - Week Ahead

Read more
8 May 2015 05:19

Earnings, Trading Statements Calendar - Week Ahead

Read more
7 May 2015 15:01

Earnings, Trading Statements Calendar - Week Ahead

Read more
7 May 2015 05:14

Earnings, Trading Statements Calendar - Week Ahead

Read more
6 May 2015 14:59

Earnings, Trading Statements Calendar - Week Ahead

Read more
6 May 2015 05:14

Earnings, Trading Statements Calendar - Week Ahead

Read more
5 May 2015 15:15

Earnings, Trading Statements Calendar - Week Ahead

Read more
23 Mar 2015 12:00

LONDON MIDDAY BRIEFING: RBS Kicks Off Further Stake Sale In Citizens

Read more
23 Mar 2015 11:22

UK WINNERS & LOSERS: Broker Ratings Changes Drive FTSE 100 Movers

Read more
23 Mar 2015 08:18

Verona Pharma Sees "Very Encouraging" Interim Results In RPL554 Trial

Read more
3 Mar 2015 12:20

UK MIDDAY BRIEFING: Barclays Profit Again Hit By Provisions

Read more
3 Mar 2015 11:33

UK WINNERS & LOSERS: Barclays Provisions Disappoint Market

Read more
3 Mar 2015 08:46

Verona Pharma To Post Less Than Expected Loss But Warns On 2015 Costs

Read more
16 Feb 2015 09:36

DIRECTOR DEALINGS: Verona Pharma CEO Buys 1 Million Shares

Read more
14 Jan 2015 15:05

Verona Pharma chairman increases stake

The chairman of Verona Pharma increased his stake in the company following Monday's news that the biotechnology firm has dosed its first group of volunteers in its asthma trial. David Ebsworth showed confidence in the future of the business by purchasing 803,107 shares for 1.35p each, spending a tot

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.